Fractional CO2 Laser Combined With PRP Fluid Versus Gel in Treatment of Acne Scars
PRP
1 other identifier
interventional
20
1 country
1
Brief Summary
This study is to test the efficacy of fractional laser combined with either PRP fluid or PRP gel in the treatment of atrophic acne scars
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for early_phase_1
Started Feb 2020
Shorter than P25 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 25, 2020
CompletedFirst Submitted
Initial submission to the registry
September 28, 2020
CompletedFirst Posted
Study publicly available on registry
October 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2021
CompletedOctober 8, 2020
September 1, 2020
10 months
September 28, 2020
October 7, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Test which combination is more effective, fractional laser with PRP fluid or fractional laser with PRP gel
Effectiveness of each combination will be measured with OCT, depth of a fixed scar on each side of the face will be measured at baseline and then compared with 1 month after the last session and 3 months after the last session
one year
Study Arms (2)
Fractional laser with PRP fluid
ACTIVE COMPARATORFractional CO2 laser then the PRP is injected afterwards
Fractional laser with PRP gel
ACTIVE COMPARATORFractional CO2 laser then the PRP gel is injected afterwards
Interventions
20 participants divided into 2 groups of 10 10 participants will do Fractional laser with PRP fluid sessions and 10 participants will do Fractional laser with PRP gel
Eligibility Criteria
You may qualify if:
- Age above 18
- Both genders
- Skin types III - V
- Willingness and ability to comply with the requirements of the protocol
- Atrophic acne scars
You may not qualify if:
- Patients with active acne
- Patients with herpes labialis, bacterial infections, other infections such as HBV. HCV or HIV.
- Oral isotretinoin use in the previous 6 months
- Pregnancy
- Tendency to keloid formation
- Patients with severe systemic illness or malignancy
- Patients with connective tissue diseases
- Patients with bleeding tendencies or any other hematological disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kasr Al Ainy Hospital
Giza, Egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dermatology Resident
Study Record Dates
First Submitted
September 28, 2020
First Posted
October 8, 2020
Study Start
February 25, 2020
Primary Completion
December 31, 2020
Study Completion
January 31, 2021
Last Updated
October 8, 2020
Record last verified: 2020-09